Protoberberine Alkaloid Coralyne Identification of Topoisomerase I as the Cytotoxic Target of the Updated

Protoberberine alkaloids (coralyne and its derivatives), which exhibit antileukemic activity in animal models, have been shown to be potent inducers of topoisomerase (topo) I-DNA cleavable complexes using punlied recombinant human DNA topo I. Different from the structurally similar benzophenanthridine alkaloid nitidine (a dual poison of both topos I and II), coralyne and its derivatives have marginal poisoning activity against DNA topo II. Yeast cells expressing human DNA topo I are shown to be specifically sensitive to killing by coralyne derivatives and nitidine, suggesting that cellular DNA topo I is their cytotoxic target. Two human camptothecin-resistant cell lines, CPT-KS and A2780/CPT-2000, which are known to express highly camptothecin-resistant topo I, are only marginally resistant to coralyne derivatives and nitidine. Purification of human topo I from Escherichia coli cells overexpressing CPT-K5 recom binant topo I has demonstrated similar marginal cross-resistance to niti dine. It seems possible to develop coralyne and nitidine derivatives as new topo I-targeted therapeutics to overcome aspects of camptothecin-related

[1]  C. Yu,et al.  Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons. , 1996, Bioorganic & medicinal chemistry.

[2]  B. D. Rogers,et al.  Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne. , 1996, Chemical research in toxicology.

[3]  Y. Pommier,et al.  Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen. , 1995, Cancer research.

[4]  L. Liu,et al.  Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. , 1993, Cancer research.

[5]  S. Hecht,et al.  Inhibition of topoisomerase I function by nitidine and fagaronine. , 1993, Chemical research in toxicology.

[6]  M. Bjornsti,et al.  Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. , 1993, The Journal of biological chemistry.

[7]  L. Wang,et al.  Inhibitors of DNA topoisomerase I isolated from the roots of Zanthoxylum nitidum , 1993 .

[8]  B. Gatto,et al.  DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Liu,et al.  The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B. , 1992, Cancer research.

[10]  S. Kaufmann,et al.  Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line. , 1991, Cancer research.

[11]  Eric Patterson,et al.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites , 1991, Nucleic Acids Res..

[12]  L. Liu,et al.  Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. , 1990, Cancer research.

[13]  J. Wang,et al.  Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. , 1989, Cancer research.

[14]  Y. Pommier,et al.  Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. , 1989, Cancer research.

[15]  K. Kohn,et al.  Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. , 1989, Cancer research.

[16]  R. A. Kim,et al.  A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings , 1989, Cell.

[17]  J. Wang,et al.  DNA topoisomerase-targeting antitumor drugs can be studied in yeast. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Suzuki,et al.  Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[20]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[21]  I. Pastan,et al.  Isolation and genetic characterization of human KB cell lines resistant to multiple drugs , 1985, Somatic cell and molecular genetics.

[22]  L. Liu,et al.  Purification and characterization of a type II DNA topoisomerase from bovine calf thymus. , 1985, The Journal of biological chemistry.

[23]  L. Liu,et al.  Cleavage of DNA by mammalian DNA topoisomerase II. , 1983, The Journal of biological chemistry.

[24]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[25]  R. L. Jones,et al.  Dimerization of coralyne and its propyl analogue and their association with DNA. , 1979, Journal of medicinal chemistry.

[26]  W. Wilson,et al.  Coralyne. Intercalation with DNA as a possible mechanism of antileukemic action. , 1976, Journal of medicinal chemistry.

[27]  K. Paull,et al.  Experimental antileukemic agents. Coralyne, analogs, and related compounds. , 1974, Journal of medicinal chemistry.

[28]  C. Cheng,et al.  Interaction between DNA and coralyne acetosulfate, an antileukemic compound. , 1973, Journal of pharmaceutical sciences.